These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3778288

  • 1. Early vitreous changes in experimental proliferative vitreoretinopathy.
    Miglior S, Kain HL, Libondi T, González RG, Barnett P, Krauss JM, Cheng HM.
    Arch Ophthalmol; 1986 Nov; 104(11):1681-4. PubMed ID: 3778288
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of cellular proliferation within the vitreous during experimental proliferative vitreoretinopathy.
    Yang CM, Olsen KR, Hernandez E, Cousins SW.
    Graefes Arch Clin Exp Ophthalmol; 1992 Nov; 230(1):66-71. PubMed ID: 1547971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A refined experimental model for proliferative vitreoretinopathy.
    Chandler DB, Quansah FA, Hida T, Machemer R.
    Graefes Arch Clin Exp Ophthalmol; 1986 Nov; 224(1):86-91. PubMed ID: 2417916
    [Abstract] [Full Text] [Related]

  • 6. Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor.
    Baudouin C, Fredj-Reygrobellet D, Ettaiche M, Barritault D, Gastaud P, Lapalus P.
    Lens Eye Toxic Res; 1992 Nov; 9(3-4):505-11. PubMed ID: 1284520
    [No Abstract] [Full Text] [Related]

  • 7. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH, Chen EP, Hatchell DL, Samsa GP, Saloupis PT, Westendorf J, Machemer R.
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy.
    Chandler DB, Rozakis G, de Juan E, Machemer R.
    Am J Ophthalmol; 1985 Jun 15; 99(6):686-90. PubMed ID: 2409802
    [Abstract] [Full Text] [Related]

  • 10. Anterior proliferative vitreoretinopathy in trauma and complicated retinal detachment. A histopathologic study.
    Mietz H, Kirchhof B, Heimann K.
    Ger J Ophthalmol; 1994 Jan 15; 3(1):15-8. PubMed ID: 8142875
    [Abstract] [Full Text] [Related]

  • 11. Proliferative vitreoretinopathy (PVR): a personal account of its pathogenesis and treatment. Proctor lecture.
    Machemer R.
    Invest Ophthalmol Vis Sci; 1988 Dec 15; 29(12):1771-83. PubMed ID: 3056866
    [No Abstract] [Full Text] [Related]

  • 12. [Vitreal and retinal changes in the fellow eye in children and adolescents with retinal detachment].
    Pytlarz E, Dałkowska A.
    Klin Oczna; 1991 Dec 15; 93(4-5):118-20. PubMed ID: 1921218
    [Abstract] [Full Text] [Related]

  • 13. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
    Steinhorst UH, Chen EP, Machemer R, Hatchell DL.
    Exp Eye Res; 1993 Apr 15; 56(4):489-95. PubMed ID: 8500561
    [Abstract] [Full Text] [Related]

  • 14. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N, Kuriyama S, Ohuchi T, Takemura M, Honda Y, Hiraoka M.
    Invest Ophthalmol Vis Sci; 1992 Feb 15; 33(2):404-9. PubMed ID: 1740372
    [Abstract] [Full Text] [Related]

  • 15. Proliferative vitreo-retinal disorders: experimental models in vivo and in vitro.
    Martini B.
    Acta Ophthalmol Suppl (1985); 1992 Feb 15; (201):1-63. PubMed ID: 1322004
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The pathogenesis of vitreoretinal proliferation and traction: a working hypothesis.
    Weller M, Heimann K, Wiedemann P.
    Med Hypotheses; 1990 Feb 15; 31(2):157-9. PubMed ID: 2325589
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T, Ogura Y, Yoshimura N, Honda Y, Wada R, Hyon SH, Ikada Y.
    Invest Ophthalmol Vis Sci; 1992 Oct 15; 33(11):3125-30. PubMed ID: 1399416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.